☰

Sankar Dutta

Affiliations: 
University of Illinois, Urbana-Champaign, Urbana-Champaign, IL 
Area:
Mathematics
Google:
"Sankar Dutta"
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor

Children

Sign in to add trainee
Jinjia Li grad student 2006 UIUC
Bart Snapp grad student 2007 UIUC
Jesse S. Beder grad student 2012 UIUC

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Lin CW, Dutta S, Ding B, et al. (2017) Pharmacokinetics, Safety, and Tolerability of Glecaprevir and Pibrentasvir in Healthy White, Chinese, and Japanese Adult Subjects. Journal of Clinical Pharmacology
Lin CW, Dutta S, Asatryan A, et al. (2017) Pharmacokinetics, Safety, and Tolerability Following Single and Multiple Doses of Pibrentasvir in a First-in-Human Study. Clinical Pharmacology in Drug Development
Lin CW, Dutta S, Asatryan A, et al. (2016) Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of ABT-493: A First-In-Human Study. Journal of Pharmaceutical Sciences
Manjula BG, Bagga R, Kalra J, et al. (2015) Labour induction with an intermediate-dose oxytocin regimen has advantages over a high-dose regimen. Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology. 35: 362-7
An G, Liu W, Katz DA, et al. (2014) Population pharmacokinetics of the 11β-hydroxysteroid dehydrogenase type 1 inhibitor ABT-384 in healthy volunteers following single and multiple dose regimens. Biopharmaceutics & Drug Disposition. 35: 417-29
Othman AA, Haig G, Florian H, et al. (2014) The H3 antagonist ABT-288 is tolerated at significantly higher exposures in subjects with schizophrenia than in healthy volunteers British Journal of Clinical Pharmacology. 77: 965-974
An G, Liu W, Katz DA, et al. (2013) Effect of ketoconazole on the pharmacokinetics of the 11β-hydroxysteroid dehydrogenase type 1 inhibitor ABT-384 and its two active metabolites in healthy volunteers: population analysis of data from a drug-drug interaction study. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 41: 1035-45
Othman AA, Haig G, Florian H, et al. (2013) Safety, tolerability and pharmacokinetics of the histamine H3 receptor antagonist, ABT-288, in healthy young adults and elderly volunteers British Journal of Clinical Pharmacology. 75: 1299-1311
Othman AA, Nothaft W, Awni WM, et al. (2012) Pharmacokinetics of the TRPV1 antagonist ABT-102 in healthy human volunteers: Population analysis of data from 3 phase 1 trials Journal of Clinical Pharmacology. 52: 1028-1041
Othman AA, Lenz RA, Zhang J, et al. (2011) Single- and multiple-dose pharmacokinetics, safety, and tolerability of the selective alpha7 neuronal nicotinic receptor agonist, ABT-107, in healthy human volunteers. Journal of Clinical Pharmacology. 51: 512-26
See more...